BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

808 related articles for article (PubMed ID: 15618242)

  • 21. Benign familial hematuria due to mutation of the type IV collagen alpha4 gene.
    Lemmink HH; Nillesen WN; Mochizuki T; Schröder CH; Brunner HG; van Oost BA; Monnens LA; Smeets HJ
    J Clin Invest; 1996 Sep; 98(5):1114-8. PubMed ID: 8787673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thin glomerular basement membrane disease.
    Frascá GM; Onetti-Muda A; Renieri A
    J Nephrol; 2000; 13(1):15-9. PubMed ID: 10720210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alport's syndrome: experience at Hôpital Necker.
    Habib R; Gubler MC; Hinglais N; Noël LH; Droz D; Levy M; Mahieu P; Foidart JM; Perrin D; Bois E; Grünfeld JP
    Kidney Int Suppl; 1982 May; 11():S20-8. PubMed ID: 6956772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hereditary nephritis mimicking immune complex-mediated glomerulonephritis.
    Nasr SH; Markowitz GS; Goldstein CS; Fildes RD; D'Agati VD
    Hum Pathol; 2006 May; 37(5):547-54. PubMed ID: 16647952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hereditary nephritis in children with and without characteristic glomerular basement membrane alterations.
    Yoshikawa N; Ito H; Matsuyama S; Hazikano H; Okada S; Matsuo T
    Clin Nephrol; 1988 Sep; 30(3):122-7. PubMed ID: 3180520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Collagen type IV-related nephropathies in Portugal: pathogenic COL4A3 and COL4A4 mutations and clinical characterization of 25 families.
    Nabais Sá MJ; Storey H; Flinter F; Nagel M; Sampaio S; Castro R; Araújo JA; Gaspar MA; Soares C; Oliveira A; Henriques AC; da Costa AG; Abreu CP; Ponce P; Alves R; Pinho L; Silva SE; de Moura CP; Mendonça L; Carvalho F; Pestana M; Alves S; Carvalho F; Oliveira JP
    Clin Genet; 2015 Nov; 88(5):456-61. PubMed ID: 25307543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laminin compensation in collagen alpha3(IV) knockout (Alport) glomeruli contributes to permeability defects.
    Abrahamson DR; Isom K; Roach E; Stroganova L; Zelenchuk A; Miner JH; St John PL
    J Am Soc Nephrol; 2007 Sep; 18(9):2465-72. PubMed ID: 17699809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alport syndrome and thin basement membrane nephropathy.
    Thorner PS
    Nephron Clin Pract; 2007; 106(2):c82-8. PubMed ID: 17570934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A clinical and morphological study of thin basement membrane disease (TBMD)].
    Sugiyama N
    Nihon Jinzo Gakkai Shi; 1994 Sep; 36(9):1010-20. PubMed ID: 7967172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical and genetic features of the Alport 'syndromes'].
    Pescucci C; Longo I; Mari F; Scala E; Bruttini M; Caselli R; Renieri A
    G Ital Nefrol; 2005; 22(5):466-76. PubMed ID: 16267804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic renal failure and shortened lifespan in COL4A3+/- mice: an animal model for thin basement membrane nephropathy.
    Beirowski B; Weber M; Gross O
    J Am Soc Nephrol; 2006 Jul; 17(7):1986-94. PubMed ID: 16775036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thin-glomerular-basement-membrane nephropathy: is it a benign cause of isolated hematuria?
    Gandhi S; Kalantar-Zadeh K; Don BR
    South Med J; 2002 Jul; 95(7):768-71. PubMed ID: 12144088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent familial hematuria in children and the locus for thin basement membrane nephropathy.
    Rana K; Wang YY; Powell H; Jones C; McCredie D; Buzza M; Udawela M; Savige J
    Pediatr Nephrol; 2005 Dec; 20(12):1729-37. PubMed ID: 16235097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal biopsy interpretation in Alport Syndrome.
    Mazzucco G; De Marchi M; Monga G
    Semin Diagn Pathol; 2002 Aug; 19(3):133-45. PubMed ID: 12180634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome.
    Cosgrove D; Liu S
    Matrix Biol; 2017 Jan; 57-58():45-54. PubMed ID: 27576055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical diagnosis of Alport's syndrome in paraffin-embedded renal sections: antigen retrieval with autoclave heating.
    Naito I; Ninomiya Y; Nomura S
    Med Electron Microsc; 2003 Mar; 36(1):1-7. PubMed ID: 12658346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of 47 novel mutations in patients with Alport syndrome and thin basement membrane nephropathy.
    Weber S; Strasser K; Rath S; Kittke A; Beicht S; Alberer M; Lange-Sperandio B; Hoyer PF; Benz MR; Ponsel S; Weber LT; Klein HG; Hoefele J
    Pediatr Nephrol; 2016 Jun; 31(6):941-55. PubMed ID: 26809805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The thin glomerular basement membrane in children with haematuria.
    Yoshikawa N; Hashimoto H; Katayama Y; Yamada Y; Matsuo T; Okada S
    J Pathol; 1984 Apr; 142(4):253-7. PubMed ID: 6716210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha 5 COLIV chain distribution in glomerular basement membrane in a male with X-linked Alport syndrome and thin basement membrane.
    Rizzoni G; Massella L; Muda AO
    Pediatr Nephrol; 2000 Dec; 15(3-4):325. PubMed ID: 11149132
    [No Abstract]   [Full Text] [Related]  

  • 40. COL4A3 mutations and their clinical consequences in thin basement membrane nephropathy (TBMN).
    Wang YY; Rana K; Tonna S; Lin T; Sin L; Savige J
    Kidney Int; 2004 Mar; 65(3):786-90. PubMed ID: 14871398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.